Neurim Pharmaceuticals Ltd provided results of a study evaluating the effects of its insomnia drug Circadin (prolonged-release melatonin) compared to Zolpidem and placebo on postural stability (body sway) in healthy middle-aged volunteers. Postural instability, also referred to as body sway, increases with age and is consider…

Three-year study tracks dopamine levels in those who suffer behavioral sleep disorders. Researchers have found that the progression of Parkinson’s disease can be detected in those who suffer from REM behavioral sleep disorders. A three-part study published by Lancet Neurology and authored by doctors at Multidisciplinary…

Alcohol is known to increase slow-wave sleep during the first half of sleep, but then become disruptive. A new study of the relationship between sleep and heart rate variability (HRV) during sleep has found that alcohol interferes with the restorative functions of sleep. Large amounts of alcohol are known to shorten sleep lat…

Apnex Medical Inc received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to begin a clinical study to evaluate the safety and effectiveness of its Hypoglossal Nerve Stimulation (HGNS) System to treat obstructive sleep apnea (OSA). Data from this clinical study are intended to s…

The benefits of continuous positive airway pressure machines (CPAP) for patients with obstructive sleep apnea (OSA) are quickly reversed when the therapy is withdrawn, according to Swiss research. The findings appear online in the articles-in-press section of the American Thoracic Society’s American Journal of Respirato…